PT - JOURNAL ARTICLE AU - Miguel, Pedraza-Meza Luis AU - Laura, Hernández-Ledesma Ana AU - Ruiz-Contreras, Alejandra E AU - Alejandra, Medina-Rivera AU - Domingo, Martínez TI - Clinical, psychosocial and demographic factors affect decisions in SLE people AID - 10.1101/2024.03.25.24304643 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.25.24304643 4099 - http://medrxiv.org/content/early/2024/03/26/2024.03.25.24304643.short 4100 - http://medrxiv.org/content/early/2024/03/26/2024.03.25.24304643.full AB - Neurological and psychiatric manifestations affect most lupus individuals and include depression, anxiety, mood disorders, and cognitive dysfunction. Although there is evidence supporting suboptimal decision-making in lupus and its association with glucocorticoids consumption, it is not clear what variables impact such decisions. The aim of this study is to explore how social, clinical, psychological, and demographic factors impact social and temporal decision-making in people with lupus. Through a within-subjects experimental-design, our participants responded to social, clinical, psychological, and demographic electronic questionnaires. Then, they participated in two behavioral economics experiments: the third-party dictator game, and the delay discounting task. Our results show that hostility, and age are essential predictors of social decisions, whereas obsessive-compulsiveness and anxiety better predict temporal decisions. These variables behave as expected, but anxiety shows unexpected results: most anxious people act patiently and prefer delayed but bigger rewards. Finally, clinical factors are critical decision predictors for social and temporal decisions. When people are in remission, they tend to impose higher punishment on those who violate the social norm, and they also tend to prefer immediate rewards. When taking glucocorticoids, they also prefer immediate rewards, and as the dosage of glucocorticoids intake increases, they tend to impose higher punishment on norm violators. Clinicians, researchers, and practitioners must consider the side effects of glucocorticoids on decision-making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by CONACYT-FORDECYT-PRONACES grants no. [11311] and [6390]. A.M.R. was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica,Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM) grants no. IA203021 and IN218023. A.L.H.L. is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and she received fellowship CVU/Becario (711015/790972) from Consejo Nacional de Humanidades, Ciencia y Tecnologia (CONAHCYT). D.M. is a posdoctoral researcher supported by Consejo Nacional de Humanidades Ciencia y Tecnologia (CONAHCYT), Estancias Posdoctorales por Mexico Convocatoria 2023(1), CVU 371892. L.M.P.M is an senior undergraduate student in Neurociencias, Universidad Nacional Autonoma de Mexico (UNAM) funded by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) with project code IN218023. He also receives a grant to continue the project abroad, financed by the Programa para el Impulso a la Titulacion por Actividades Academicas en el Extranjero (PITAAE).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Neurobiology Institute at the National Autonomous University of Mexico (protocol 093) gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData is available on https://zenodo.org/records/10806272. All the analyses were developed and implemented in R version 4.3.3 (2024-02-29), and they are available on: https://github.com/NeuroGenomicsMX/Factors_affecting_decisions_in_SLE.